Bank of New York Mellon Corp Boosts Holdings in InfuSystem Holdings, Inc. (NYSE:INFU)

Bank of New York Mellon Corp raised its position in InfuSystem Holdings, Inc. (NYSE:INFU) by 14.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 91,219 shares of the company’s stock after purchasing an additional 11,436 shares during the period. Bank of New York Mellon Corp owned 0.43% of InfuSystem worth $771,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in INFU. BNP Paribas Financial Markets raised its stake in InfuSystem by 66.4% in the third quarter. BNP Paribas Financial Markets now owns 4,076 shares of the company’s stock valued at $27,000 after purchasing an additional 1,626 shares in the last quarter. Legato Capital Management LLC purchased a new stake in shares of InfuSystem during the 4th quarter valued at $85,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of InfuSystem during the 3rd quarter worth $87,000. JPMorgan Chase & Co. lifted its holdings in shares of InfuSystem by 74.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 15,556 shares of the company’s stock worth $104,000 after acquiring an additional 6,623 shares during the last quarter. Finally, Barclays PLC grew its position in InfuSystem by 300.5% in the third quarter. Barclays PLC now owns 28,597 shares of the company’s stock worth $192,000 after acquiring an additional 21,457 shares in the last quarter. 71.13% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have commented on the stock. StockNews.com raised shares of InfuSystem from a “buy” rating to a “strong-buy” rating in a research note on Friday, March 14th. Sidoti upgraded shares of InfuSystem to a “strong-buy” rating in a research report on Tuesday, March 18th.

InfuSystem Price Performance

INFU opened at $6.04 on Thursday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. The stock’s 50 day simple moving average is $7.32 and its 200 day simple moving average is $7.54. The firm has a market cap of $126.89 million, a price-to-earnings ratio of 100.68 and a beta of 1.75. InfuSystem Holdings, Inc. has a 1 year low of $5.29 and a 1 year high of $9.97.

InfuSystem Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.